Browsing by Author "Jaklitsch, Michael"
Now showing items 1-2 of 2
-
Identification of Metastatic Nodal Disease in a Phase 1 Dose-Escalation Trial of Intraoperative Sentinel Lymph Node Mapping in Non–small Cell Lung Cancer Using Near-Infrared Imaging
Gilmore, Denis M.; Khullar, Onkar V.; Jaklitsch, Michael; Chirieac, Lucian; Frangioni, John V.; Colson, Yolonda (Elsevier BV, 2013-09)Objectives Early stage non-small cell lung cancer (NSCLC) has a high recurrence rate and poor 5-yearsurvival, particularly if lymph nodes are involved. Our objective was to perform a dose escalationstudy to assess safety ... -
Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer
Cleary, James M.; Mamon, Harvey J.; Szymonifka, Jackie; Bueno, Raphael; Choi, Noah; Donahue, Dean M.; Fidias, Panos M.; Gaissert, Henning A.; Jaklitsch, Michael T.; Kulke, Matthew H.; Lynch, Thomas P.; Mentzer, Steven J.; Meyerhardt, Jeffrey A.; Swanson, Richard S.; Wain, John; Fuchs, Charles S.; Enzinger, Peter C. (BioMed Central, 2016)Background: Patients with locally advanced esophageal cancer who are treated with trimodality therapy have a high recurrence rate. Preclinical evidence suggests that inhibition of cyclooxygenase 2 (COX2) increases the ...